by Alison Bass | Jun 8, 2011 | antidepressants, conflicts of interest, expert testimony, medical devices, National Institutes of Health
A few weeks ago, I blogged about the strange case of Dr. Helen Mayberg, a neurologist at Emory University who has testified in more death penalty cases in recent years than almost any other doctor in the country. I highlighted Mayberg’s lucrative and lethal (she...
by Alison Bass | May 17, 2011 | conflicts of interest, expert testimony, medical devices, National Institutes of Health, patient care
A year ago, the Department of Health and Human Services proposed new rules governing the disclosure and handling of financial conflicts of interest by medical researchers who receive federal funding. The more stringent rules were prompted by Congressional findings...
by Alison Bass | May 13, 2011 | antidepressants, ghostwriting, pharmaceutical industry
In his latest blog, Paul Thacker, an investigator for the Project on Government Oversight (POGO) and former aide to Senator Charles Grassley, struggles to understand how Dr. Stan Kutcher, a psychiatrist turned politician in Canada, could possibly say that Paxil study...
by Alison Bass | May 3, 2011 | Uncategorized
Stan Kutcher, the psychiatrist turned politician who threatened to sue The Coast newspaper in Halifax unless it issued a retraction on a story it did about Kutcher’s involvement with Paxil study 329 (see retracted story here) and my blog about it), lost...
by Alison Bass | May 1, 2011 | Uncategorized
In recent years, experts (like Bill Kovach and Tom Rosenstiel) have warned that press freedoms are under increasing threat from economic pressures. As advertising and readers flee to the Web, they say, news outlets are more likely to cave in to pressure from corporate...
